Targeted delivery of anticancer drugs by aptamer AS1411 mediated Pluronic F127/cyclodextrin-linked polymer composite micelles

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 11, Issue 1, 2015, Pages 175-184

  Li, Xin ^b   Yu, Yang ^b   Ji, Qian ^b   Qiu, Liyan ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Aptamer; Composite micelles; Cyclodextrin; Doxorubicin; Pluronic F127

Indexed keywords

CYCLODEXTRINS; DRUG DELIVERY; DRUG PRODUCTS; MOLECULAR BIOLOGY; NUCLEIC ACIDS; POLYETHYLENE GLYCOLS; TUMORS;

ANTI-TUMOR ACTIVITIES; APTAMERS; BETA-CYCLODEXTRIN; DOXORUBICIN; LOADING CAPACITIES; MOLECULAR TARGETS; MULTIFUNCTIONAL COMPOSITES; PLURONIC F-127;

MICELLES;

APTAMER; APTAMER AS1411; BETA CYCLODEXTRIN; DOXORUBICIN; NUCLEOLIN; POLOXAMER; POLYMER; UNCLASSIFIED DRUG; AGRO 100; ANTINEOPLASTIC AGENT; BETA CYCLODEXTRIN DERIVATIVE; CYCLODEXTRIN; MACROGOL DERIVATIVE; MICELLE; OLIGODEOXYRIBONUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD; BREAST TUMOR; CANCER THERAPY; CARDIOTOXICITY; CIRCULATION TIME; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; MICELLE; MOUSE; NONHUMAN; ANIMAL; BREAST NEOPLASMS; CANCER TRANSPLANTATION; CELL PROLIFERATION; CHEMISTRY; METABOLISM; NANOMEDICINE; PROCEDURES; TUMOR CELL LINE;

MUS;

ANIMALS; ANTINEOPLASTIC AGENTS; BETA-CYCLODEXTRINS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLODEXTRINS; DOXORUBICIN; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; MICE; MICELLES; NANOMEDICINE; NEOPLASM TRANSPLANTATION; OLIGODEOXYRIBONUCLEOTIDES; POLOXAMER; POLYETHYLENE GLYCOLS;

EID: 84919694641     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2014.08.013     Document Type: Article

References (27)

1. Alves N.J., Kiziltepe T., Bilgicer B. Oriented surface immobilization of antibodies at the conserved nucleotide binding site for enhanced antigen detection. Langmuir 2012, 28:9640-9648.
2. Zhu L., Kate P., Torchilin V.P. Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting. ACS Nano 2012, 6:3491-3498.
3. Yabbarov N.G., Posypanova G.A., Vorontsov E.A., Obydenny S.I., Severin E.S. A new system for targeted delivery of doxorubicin into tumor cells. J Control Release 2013, 168:135-141.
4. Liu Y.H., Sun J., Cao W., Yang J.H., Lian H., Li X., et al. Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery. Int J Pharm 2011, 421:160-169.
5. Koren E., Apte A.I., Jani A., Torchilin V.P. Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity. J Control Release 2012, 160:264-273.
6. Chiappetta D.A., Sosnik A. Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs. Eur J Pharm Biopharm 2007, 66:303-317.
7. Chung Y., Kim J.C., Kim Y.H., Tae G., Lee S., Kim K., et al. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting. J Control Release 2010, 143:374-382.
8. Zhao L.Y., Du C.H., Duan Y.W., Zang Y.N., Zhang H.S., Yang C.F., et al. Curcumin loaded mixed micelles composed of Pluronic P123 and F68: preparation, optimization and in vitro characterization. Colloids Surf B Biointerfaces 2012, 97:101-108.
9. Qiu L.Y., Wang R.J., Zheng C., Jin Y., Jin L.Q. β-Cyclodextrin-centered star-shaped amphiphilic polymers for doxorubicin delivery. Nanomedicine 2010, 5:193-208.
10. Tuerk C., Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990, 249:505-510.
11. Ellington A.D., Szostak J.W. In vitro selection of RNA molecules that bind specific ligands. Nature 1990, 346:818-822.
12. Tan W.H., Wang H., Chen Y., Zhang X.B., Zhu H.Z., Yang C.Y., et al. Molecular aptamers for drug delivery. Trends Biotechnol 2011, 29:634-640.
13. Li X., Zhao Q.H., Qiu L.Y. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy. J Control Release 2013, 171:152-162.
14. Hernandez F.J., Hernandez L.I., Pinto A., Schäfer T., Ö zalp V.C. Targeting cancer cells with controlled release nanocapsules based on a single aptamer. Chem Commun 2013, 49:1285-1287.
15. Bates P.J., Laber D.A., Miller D.M., Thomas S.D., Trent J.O. Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer. Exp Mol Pathol 2009, 86:151-164.
16. Rizzieri D., Stockerl-Goldstein K., Wei A., Herzig R.H., Erlandsson F., Stuart R.K. Long-term outcomes of responders in a randomized, controlled phase II trial of aptamer AS1411 in AML. J Clin Oncol 2010, 28:6557.
17. Aliabadi H.M., Elhasi S., Mahmud A., Gulamhusein R., Mahdipoor P., Lavasanifar A. Encapsulation of hydrophobic drugs in polymeric micelles through co-solvent evaporation: the effect of solvent composition on micellar properties and drug loading. Int J Pharm 2007, 329:158-165.
18. Lee H., Ahn C.H., Park T.G. Poly[lactic-co-(glycolic acid)]-grafted hyaluronic acid copolymer micelle nanoparticles for target-specific delivery of doxorubicin. Macromol Biosci 2009, 9:336-342.
19. Hong R.L., Huang C.J., Tseng Y.L., et al. Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumorbearing mice: is surface coating with polyethylene glycol beneficial?. Clin Cancer Res 1999, 5:3645-3652.
20. Tagami T., Ernsting M.J., Li S.D. Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicin. J Control Release 2011, 152:303-309.
21. Zhang W.J., Gilstrap K., Wu L.Y., Remant Bahadur K.C., Moss M.A., Wang Q., et al. Synthesis and characterization of thermally responsive Pluronic F127 chitosan nanocapsules for controlled release and intracellular delivery of small molecules. ACS Nano 2010, 4:6747-6759.
22. Zhou Q., Guo X., Chen T., Zhang Z., Shao S.J., Luo C., et al. Target-specific cellular uptake of folate-decorated biodegradable polymer micelles. J Phys Chem B 2011, 115:12662-12670.
23. Allen C., Maysinger D., Eisenberg A. Nano-engineering block copolymer aggregates for drug delivery. Colloids Surf B Biointerfaces 1999, 16:3-27.
24. Min K.H., Kim J.H., Bae S.M., Shin H., Kim M.S., Park S.J., et al. Tumoral acidic pH-responsive MPEG-poly(β-amino ester) polymeric micelles for cancer targeting therapy. J Control Release 2010, 144:259-266.
25. Weissleder R. A clearer vision for in vivo imaging. Nat Biotechnol 2001, 19:316-317.
26. Chen X., Kube D.M., Cooper M.J., Davis P.B. Cell surface nucleolin serves as receptor for DNA nanoparticles composed of PEGylated polylysine and DNA. Mol Ther 2007, 16:333-342.
27. Dam D.H.M., Lee J.H., Sisco P.N., Co D.T., Zhang W. Direct observation of nanoparticle-cancer cell nucleus interactions. ACS Nano 2012, 6:3318-3326.